# Targeted Small Airways Therapy in Persistent Asthma

> **NCT01894048** · PHASE4 · COMPLETED · sponsor: **University of Dundee** · enrollment: 26 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Qvar® (beclometasone dipropionate HFA)

## Key facts

- **NCT ID:** NCT01894048
- **Lead sponsor:** University of Dundee
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-28
- **Primary completion:** 2018-06-25
- **Final completion:** 2018-06-25
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2019-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01894048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01894048, "Targeted Small Airways Therapy in Persistent Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01894048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*